What is Sentiar?
Sentiar is a pioneering digital health and medical technology enterprise dedicated to revolutionizing interventional procedures through the application of augmented reality and real-time holographic visualization. The company's core software platform provides clinicians with an immersive, three-dimensional environment, enabling precise interaction with patient anatomy and catheter positioning during minimally invasive surgeries. By bridging the gap between complex imaging data and real-time procedural guidance, Sentiar enhances workflow efficiency and clinical decision-making. This technological advancement is designed to improve patient outcomes by providing healthcare professionals with intuitive, high-fidelity visual feedback, thereby reducing the cognitive load associated with traditional two-dimensional imaging modalities.
How much funding has Sentiar raised?
Sentiar has raised a total of $16.3M across 5 funding rounds:
Angel/Seed
$1.1M
Debt
$144K
Series A
$5.1M
Series B
$8.5M
Debt
$1.5M
Angel/Seed (2017): $1.1M, investors not publicly disclosed
Debt (2021): $144K led by PPP
Series A (2021): $5.1M supported by QRM Capital, Cultivation Capital, TechWald Holding S.p.A, BioGenerator Company, Keiretsu Forum, Neue Fund, and VCapital
Series B (2023): $8.5M featuring VCapital, MedVenture Partners, and TechWald Holding SpA
Debt (2026): $1.5M, investors not publicly disclosed
Key Investors in Sentiar
Cultivation Capital
Cultivation Capital is a venture capital firm that invests in young companies with transformative ideas across various industries, including life sciences, software, agriculture, and geospatial technology.
Keiretsu Forum
Keiretsu Forum is a global investment community comprised of angel investors, venture capitalists, and corporate institutional investors focused on early-stage and growth-stage opportunities.
VCapital
VCapital is a Chicago-based venture capital firm that targets early-stage companies with the potential for exceptional, profitable growth across the medical device and biotechnology sectors.
What's next for Sentiar?
With the successful acquisition of this latest financing, Sentiar is poised to enter a phase of aggressive market expansion and product refinement. The strategic focus will likely shift toward deepening the integration of its holographic software within existing hospital infrastructure and expanding its clinical application suite to cover a broader range of minimally invasive procedures. As the company moves beyond its current lifecycle stage, the emphasis will remain on maintaining high-precision standards while scaling its commercial footprint. Future growth will be supported by the continued backing of its institutional partners, who are focused on the long-term viability of digital health solutions that offer measurable improvements in procedural safety and clinical efficacy.
See full Sentiar company page
